Simply rule out cancer

Simply rule
out cancer

About us

HT Vista LTD is the UK subsidiary of HT Bioimaging (HTVET), an Israeli-based company, founded in 2017. Our mission is to promote early diagnosis of cancer and save pets’ lives, by empowering clinicians to rule out cancer quickly and confidently.

Our product

HT Vista device is the first AI-driven non-invasive screening tool that allows vets & nurses to rule out cancer of dermal & subcutaneous masses in dogs. By using our unique Heat Diffusion Imaging (HDI) technology & cloud-based analysis, vets & nurses are now able to rule out cancer on-the-spot and in their own practice.

Our product

HT Vista deviceis the first AI-driven non-invasive screening tool that allows vets & nurses to rule out cancer of dermal & subcutaneous masses in dogs. By using our unique Heat Diffusion Imaging (HDI) technology & cloud-based analysis, vets & nurses are now able to rule out cancer on-the-spot and in their own practice.

Traditionally, identifying dermal and subcutaneous masses in dogs is a time-consuming, invasive, and expensive process, involving sending biopsy results to the lab for analysis. As a result, ruling out cancer takes longer, leading to significant pet owner distress, and treatment in the case of a cancer diagnosis is unduly delayed. Not anymore.

Our technology

The underlying principle of HT Vista Heat Diffusion Imaging (HDI) technology is that benign and malignant tissues display different Heat Transfer Rates due to differences in composition, metabolism, tissue morphology, and vascular network, which affect their thermophysical properties. This innovative screening modality relies on the unique thermal signals recorded by the device, as the tissue is heated and left to cool down.

Meet the team

We come from diverse backgrounds and specialize in different fields – veterinary medicine, algorithms, engineering, design, and more. Together, we form an expert team, backed by vast experience, and highly motivated to drive real change and innovate the field of cancer diagnosis in pets around the world.

Noa Chen

CFO

Noa Chen

CFO

Shani Toledano

Co-Founder & CEO

Shani Toledano

Co-Founder & CEO

Gideon Barak

Co-Founder & Chairman

Gideon Barak

Co-Founder & Chairman

Gillian Dank, DACVIM (O), D-ECVIM Ca (Oncology)

Chief Veterinary Officer

Gillian Dank, DACVIM (O), D-ECVIM Ca (Oncology)

Chief Veterinary Officer

Liron Levy-Hirsch

Managing Director UK

Liron Levy-Hirsch

Managing Director UK

Tali Buber, DVM

Veterinary Medical Director

Tali Buber, DVM

Veterinary Medical Director

Aviv Ben Dov

Business Development Manager

Aviv Ben Dov

Business Development Manager

Hen Toledano

VP R&D

Hen Toledano

VP R&D

Tal Dembinsky, DVM

Veterinarian

Tal Dembinsky, DVM

Veterinarian

Yuri Osokin

Head of AI

Yuri Osokin

Head of AI

Marlen Ben David

Software & cloud team leader

Marlen Ben David

Software & cloud team leader

Kai

Kai

Harley

Harley

Milkey

Milkey

Julie

Julie

Shani Toledano

Co-Founder & CEO

Shani Toledano

Co-Founder & CEO

Gideon Barak

Co-Founder & Chairman

Gideon Barak

Co-Founder & Chairman

Noa Chen

CFO

Noa Chen

CFO

Gillian Dank, DACVIM (O), D-ECVIM Ca (Oncology)

Chief Veterinary Officer

Gillian Dank, DACVIM (O), D-ECVIM Ca (Oncology)

Chief Veterinary Officer

Liron Levy-Hirsch

Managing Director UK

Liron Levy-Hirsch

Managing Director UK

Tali Buber, DVM

Veterinary Medical Director

Tali Buber, DVM

Veterinary Medical Director

Aviv Ben Dov

Business Development Manager

Aviv Ben Dov

Business Development Manager

Hen Toledano

VP R&D

Hen Toledano

VP R&D

Tal Dembinsky, DVM

Veterinarian

Tal Dembinsky, DVM

Veterinarian

Yuri Osokin

Head of AI

Yuri Osokin

Head of AI

Marlen Ben David

Software & cloud team leader

Marlen Ben David

Software & cloud team leader

Four Legged Employees

Kai

Kai

Harley

Harley

Milkey

Milkey

Julie

Julie

Activities

we participate in conferences and events around the world. Be sure to follow us on social media, so you can be among the first to know which global event we’ll be attending next, and join us in person, to learn more about our company and watch our innovative device in action.

Testimonials

Michael S Kent

MAS, DVM, DACVIM (RO),
DACVIM (O), ECVDI (RO)

MAS, DVM, DACVIM (RO),
DACVIM (O), ECVDI (RO)

MAS, DVM, DACVIM (RO),
Professor, Director of the Center for Companion Animal Health, Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California – Davis

Professor, Director of the
Center for Companion Animal
Health, Department of Surgical
and Radiological Sciences,
School of Veterinary Medicine,
University of California – Davis

Michael Petty

DVM, CVPP, CVMA, CCRT, CAAPM
Arbor Pointe Veterinary Hospital, Canton, Michigan, USA

The revolutionary device that’s empowering
veterinarians to detect & diagnose cancer earlier

HT Vista in numbers

Thousands

Scanned Masses

0 %

Negative Predictive Value

0 %

Sensitivity

HT Vista in numbers

Thousands

Scanned masses

0 %

Negative Predictive Value

0 %

Sensitivity

The revolutionary device that’s
empowering veterinarians to
detect & diagnose cancer earlier

Discover the Difference
HT Vista Can Make for Your Veterinary Practice

In the Press

Testimony of Colorado veterinary clinic
February 25, 2023
Forbes – The Cutting-Edge Technology Ruling Out Cancer In Dogs In Veterinary Clinics
Mar 30, 2023
Authority magazine
Female Disruptors: Shani Toledano of HTVet On The Three Things You Need To Shake Up Your Industry
Dec 26, 2022
Vet Times
New canine scanner launches in the UK
November 30, 2022
The marker
PROTECTING YOUR PETS AND HELPING DETECT CANCER IN PEOPLE
Nov 16, 2022
Veterinary Pracrice
HT Vista is the first non-invasive device to rule out cancer of subcutaneous and dermal masses
14 September 2022
HT Vista in Detroit news.
Business wire Partnership with Companion Animal Health